Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01664936 · ClinicalTrials.gov registry record
Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
A clinical trial of Head and Neck Cancers, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT01664936 is a study of Head and Neck Cancers that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 27 participants, below the 196-participant average among 6 other Head and Neck Cancers trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01664936, a study of Head and Neck Cancers, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if a new way of imaging called the Cerenkov luminescence or effect that is used with a standard clinical PET/CT and/or investigation scans can be done in order to capture tumor sizes. The investigators believe endoscopies and surgical procedures could benefit from this type of imaging in the future. The Cerenkov imaging could be used as a guide for surgical resections. The purpose of this study is to use the Cerenkov light from FDG, Iodine-131 tracer sand/or other investigational tracers to image tumors and its sizes in the head, neck, breast, axillary and pelvic regions with a highly sensitive camera. The investigators will be trying to see if we can get another picture of the tumor using the Cerenkov light as part of the standard clinical scan or therapy.
Conditions Studied
Interventions
- RADIATION Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I
Study Locations (1)
New York
- Memorial Sloan-Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2012-08-08 |
| Est. Completion | 2018-04-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01664936
The ClinicalTrials.gov registry entry for NCT01664936 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 196-participant average among 6 other Head and Neck Cancers trials with a reported enrollment target (86% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head and Neck Cancers appearing as the primary indexed condition, and to 1 intervention - of which Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I is the first listed.
NCT01664936 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01664936 about?
NCT01664936 is a clinical study titled "Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes". The purpose of this study is to see if a new way of imaging called the Cerenkov luminescence or effect that is used with a standard clinical PET/CT and/or investigation scans can be done in order to capture tumor sizes. The investigators believe endoscopies and surgical procedures could benefit from...
What is the current status of trial NCT01664936?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2012-08-08. Estimated completion is 2018-04-03.
What conditions does trial NCT01664936 study?
This clinical trial studies the following conditions: Head and Neck Cancers.
What interventions are being tested in trial NCT01664936?
The interventions under investigation include: Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I (RADIATION).
Who is sponsoring clinical trial NCT01664936?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01664936 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
RECRUITING
-
Comprehensive Outcomes for After Cancer Health
RECRUITING · NA
-
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
COMPLETED
-
A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.